| Screening tests for Inborn Errors of Metabolism (DNB 1996/2)10 | 104 | 1996 |
| Discuss the diet plan in various metabolic disorders (DNB 1999/1)15 | 104 | 1999 |
| Laboratory Screening tests for metabolic Disorders (DNB 2006/1)10 | 104 | 2006 |
| Discuss the enzymes replacement therapy and substrate reduction strategies in management of metabolic disease (DNB 2008/2)10 | 104 | 2008 |
| Approach to IEM (DNB 2019/1)5, (DNB 2018/2)5 | 104 | 2019 |
| Approach to a suspected case of Inborn Errors of Metabolism (DNB 2022/1)5 | 104 | 2022 |
| Metabolic autopsy (DNB 2020/2)5 | 104 | 2020 |
| Newborn screening is useful in which conditions and how it can be done (DNB 2018/1)6 | 104 | 2018 |
| New-born screening test in relation to endocrinology (DNB 2019/2)5 | 104 | 2019 |
| Newborn Screening Tests and Interpretation (DNB 2021/2)5 | 104 | 2021 |
| Role of newborn screening (DNB 2023/1)5 | 104 | 2023 |
| Describe the screening tests for IEM (DNB 2023/1)5 | 104 | 2023 |
| Newborn screening program in Indian context (DNB 2024/2)5 | 104 | 2024 |
| Homocysteinuria (DNB 1994/2)15 | 105 | 1994 |
| Enlist the inborn errors of metabolism (IEM) with their associated peculiar odor. Provide the investigative approach for an infant with suspected IEM. Describe the treatment of phenylketonuria (DNB 2009/2)4+4+2 | 105 | 2009 |
| Provide a diagrammatic representation of urea cycle. Indicate and name related disorders of urea cycle metabolism at each step (DNB 2008/1)10, (DNB 2015/2)10 | 105 | 2008 |
| Clinical features of Tyrosinemia type 1 (DNB 2018/2)5 | 105 | 2018 |
| Diagrammatic representation of urea cycle (DNB 2020/1)5 | 105 | 2020 |
| Management of hyperammonemia (DNB 2020/1)5 | 105 | 2020 |
| Urea cycle disorders (DNB 2021/2)5 | 105 | 2021 |
| Alkaptonuria (DNB 2023/2)5 | 105 | 2023 |
| Metachromatic Leukodystrophy (DNB 1996/1)12 | 106 | 1996 |
| Write Briefly about glucose metabolism in body. Describe Briefly glycogen storage disorders (DNB 2004/2)4+6 | 107 | 2004 |
| Pattern of inheritance and diagnosis of mitochondrial diseases (DNB 2022/1)5 | 108 | 2022 |
| Diagnostic algorithm for suspected mitochondrial disease (DNB 2022/2)5 | 108 | 2022 |
| Diagnostic testing for Mitochondrial disease (DNB 2023/2)5 | 108 | 2023 |
| Mucopolysaccharidoses - Classification and clinical features (DNB 2021/2)6 | 109 | 2021 |
| Progeria (DNB 2019/2)6 | 111 | 2019 |
| Molecular pathogenesis of Progeria (DNB 2023/2)5 | 111 | 2023 |
| Glucose homeostasis in infants (DNB 2021/1)5 | 113 | 2021 |
| Diagnostic approach in a 2 year old child who presents with recurrent episodes of symptomatic hypoglycemia (DNB 2021/1)5 | 113 | 2021 |
| Diagnosis and management of hyperinsulinemic hypoglycemia beyond neonatal period (DNB 2022/2)5 | 113 | 2022 |
| Diagnosis and management of phenylketonuria (DNB 2025/1)5 | 105 | 2025 |